189 related articles for article (PubMed ID: 9013384)
21. Neurotoxin domoic acid produces cytotoxicity via kainate- and AMPA-sensitive receptors in cultured cortical neurones.
Larm JA; Beart PM; Cheung NS
Neurochem Int; 1997 Nov; 31(5):677-82. PubMed ID: 9364453
[TBL] [Abstract][Full Text] [Related]
22. Effect of intrathecal non-NMDA EAA receptor antagonist LY293558 in rats: a new class of drugs for spinal anesthesia.
Von Bergen NH; Subieta A; Brennan TJ
Anesthesiology; 2002 Jul; 97(1):177-82. PubMed ID: 12131120
[TBL] [Abstract][Full Text] [Related]
23. The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
Ohno K; Okada M; Tsutsumi R; Sakamoto S; Yamaguchi T
Jpn J Pharmacol; 1998 Jan; 76(1):105-8. PubMed ID: 9517411
[TBL] [Abstract][Full Text] [Related]
24. (3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
Ornstein PL; Arnold MB; Allen NK; Leander JD; Tizzano JP; Lodge D; Schoepp DD
J Med Chem; 1995 Dec; 38(25):4885-90. PubMed ID: 8523401
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.
Hicks CA; Ward MA; Ragumoorthy N; Ambler SJ; Dell CP; Dobson D; O'Neill MJ
Brain Res; 1999 Feb; 819(1-2):65-74. PubMed ID: 10082862
[TBL] [Abstract][Full Text] [Related]
26. Protection against non-NMDA receptor-mediated excitotoxicity by GYKI 52466 in mature telencephalic cultures of the rat.
Kovács AD; Egyed A
Neurobiology (Bp); 1996; 4(1-2):59-72. PubMed ID: 9116695
[TBL] [Abstract][Full Text] [Related]
27. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
May PC; Robison PM; Fuson KS
Neurosci Lett; 1999 Mar; 262(3):219-21. PubMed ID: 10218895
[TBL] [Abstract][Full Text] [Related]
28. Role of desensitization of AMPA receptors on the neuronal viability and on the [Ca2+]i changes in cultured rat hippocampal neurons.
Ambrósio AF; Silva AP; Malva JO; Mesquita JF; Carvalho AP; Carvalho CM
Eur J Neurosci; 2000 Jun; 12(6):2021-31. PubMed ID: 10886341
[TBL] [Abstract][Full Text] [Related]
29. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
[TBL] [Abstract][Full Text] [Related]
30. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
[TBL] [Abstract][Full Text] [Related]
32. The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain.
Lee HJ; Pogatzki-Zahn EM; Brennan TJ
J Pain; 2006 Oct; 7(10):768-77. PubMed ID: 17018337
[TBL] [Abstract][Full Text] [Related]
33. The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation.
Stanfa LC; Dickenson AH
Neuroscience; 1999; 93(4):1391-8. PubMed ID: 10501464
[TBL] [Abstract][Full Text] [Related]
34. Sustained ethanol inhibition of native AMPA receptors on medial septum/diagonal band (MS/DB) neurons.
Frye GD; Fincher A
Br J Pharmacol; 2000 Jan; 129(1):87-94. PubMed ID: 10694206
[TBL] [Abstract][Full Text] [Related]
35. Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
O'neill MF; Sanger G; Ornstein PL; Osborne DJ; Woodhouse SM
Psychopharmacology (Berl); 2005 Apr; 179(1):181-8. PubMed ID: 15821949
[TBL] [Abstract][Full Text] [Related]
36. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
38. Blockade of AMPA/kainate receptors can either decrease or increase the survival of cultured neocortical cells depending on the stage of maturation.
Drian MJ; Bardoul M; König N
Neurochem Int; 2001 May; 38(6):509-17. PubMed ID: 11248399
[TBL] [Abstract][Full Text] [Related]
39. Role of desensitization and subunit expression for kainate receptor-mediated neurotoxicity in murine neocortical cultures.
Jensen JB; Schousboe A; Pickering DS
J Neurosci Res; 1999 Jan; 55(2):208-17. PubMed ID: 9972823
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.
Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
J Med Chem; 1996 May; 39(11):2232-44. PubMed ID: 8667366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]